Krka d. d
Research Krka d. d (KRK) on Bullrun: market cap PLN 34.33B, P/E 18.8, dividend yield 3.6%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerKRK
- ExchangeWAR
- CountrySlovenia
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyPLN
- Market capPLN 34.33B
- P/E18.8
- Dividend yield3.6%
- Financial periodQ2 2026
- RevenueEUR 553.57M
- Net incomeEUR 139.31M
- Free cash flowEUR 100.23M
- Gross margin61.5%
Valuation Snapshot
latest market cap is PLN 34.33B; P/E is 18.8; dividend yield is 3.6%.
Peer valuation comparison
Latest P/E is 18.8x versus a Healthcare sector median of 24.67x (23.8% below).
Latest dividend yield is 3.56% versus a Healthcare sector median of 1.84% (93.5% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | EUR 2.04B | EUR 403.24M | EUR 430.27M | 58.0% | n/a | EUR 347.82M | EUR 18.36M | EUR 2.36B |
| FY2024 | EUR 1.91B | EUR 356.20M | EUR 253.17M | 57.3% | 11.6 | EUR 344.90M | EUR 13.15M | EUR 2.22B |
| FY2023 | EUR 1.81B | EUR 313.73M | EUR 97.23M | 56.8% | 10.14 | EUR 174.01M | n/a | EUR 2.16B |
| FY2022 | EUR 1.72B | EUR 363.66M | EUR 379.75M | 56.7% | 11.69 | EUR 518.93M | n/a | EUR 2.14B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-09-28 | PLN 34.33B | 18.8 | 3.5% | 39.4 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 39.4 PLN, yield 3.6%.
| Year | Dividends/share |
|---|---|
| FY2024 | 32.76 EUR |
| FY2023 | 28.83 EUR |
| FY2022 | 24.59 EUR |
About Krka d. d
Krka, d. d., a generic pharmaceutical company, develops, produces, markets, and sells prescription pharmaceuticals, non-prescription products, and animal health products in Slovenia, South-East Europe, East Europe, Central Europe, West Europe, and internationally. The company offers prescription pharmaceuticals for cardiovascular, central nervous system, gastrointestinal tract, pain, diabetes, and other therapeutic areas.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Krka d. d's market cap?
Krka d. d's market capitalization is PLN 34.33B.
What is Krka d. d's P/E ratio?
Krka d. d's price-to-earnings (P/E) ratio is 18.8.
Does Krka d. d pay a dividend?
Krka d. d has a dividend yield of 3.6%.
What does Krka d. d do?
Krka, d. d., a generic pharmaceutical company, develops, produces, markets, and sells prescription pharmaceuticals, non-prescription products, and animal health products in Slovenia, South-East Europe, East Europe, Central Europe, West Europe, and internationally. The company offers prescription pharmaceuticals for cardiovascular, central nervous system, gastrointestinal tract, pain, diabetes, and other therapeutic areas.